The RWD & RWE Podcast

09 March 2022: Conversation with Sadiqa Mahmood DDS MPH, General Manager & SVP Life Sciences Business at Health Catalyst – We discussed Sadiqa's career transition into real world healthcare data, her passion for improving RWD quality, and the need for industry metrics with a quality framework. [Sadiqa also shared some insights from her passion for car racing with Formula 1.]

02 March 2022: Conversation with Steve Galen, PhD, Galen F P Solutions – Leveraging Steve's vast experience in mathmatical simulation for engineering, now applied to clinical research, we will have a non-technical conversation about the business implications of simulations that can optimize clinical trials and RWE studies.

23 February 2022: Conversation with Keith Kallmes & Kevin Kallmes JD MA from Nested Knowledge – A non-technical, exploratory conversation about machine learning in the systematic review of published literature and its impact on real-world evidence generation today.

16 February 2022: Conversation with Micah Lieberman, Marina Filshtinsky MD, Executive Directors at Cambridge Healthtech Institute – The SCOPE 2022 meeting was held Feb 7-10, 2022 with a hybrid attendance model: in-person and virtual. There was great attendance and there were great topics in all the tracks. This is a discussion with the organizers from SCOPE and attendees regarding the RWD/RWE presentations & exhibitors that stood out. ***Apologies for the technical audio issues with the Clubhouse app the impacted this discussion!***

02 February 2022: Conversation with Andy Wilson PhD MSTAT, Head of Innovative RWD Analytics at Parexel and self-proclaimed "Causal & predictive analytics enthusiast" – The ‘Cause Conundrum’ - how & why the use of RWD in life science research challenges traditional biostatistical dogma. Viewpoint: Awareness and understanding are critical for industry to fully-embrace the value of RWD for RWE.

26 January 2022: Conversation with Neil Belson JD MS, Law Office of Neil A Belson – Mr. Belson is a private practice attorney and Harvard Law alumni, focused exclusively on life science and medtech sectors. This is an open conversation about many of the legal issues associated with RWD use and RWE generation in life science research.

19 January 2022: Sheng Feng PhD MS, Chief Data Scientist at LinkDoc – We will discuss RWD in China, specifically the recent significant advancements in the use of RWD in China (including for regulatory decision-making).

12 January 2022: Conversation with Jane Myles MSc, VP, Clinical Trial Innovation at Curebase – We discuss some of the evolving areas in decentralized research trials/studies (DCTs) where RWD is having an impact and ways that the research ecosystem is changing.

05 January 2022: Conversation with Special Guest: Steve Labkoff MD FACP FACMI FAMIA:- Global Head Clinical & Healthcare Informatics at Quantori- Former Chief Data Officer for the MMRF- Former Exec Dir of Pfizer, AstraZeneca Informatics teams- Harvard & MIT trained Medical InformaticianHe reflects on the evolution of patient registries from RWD, medical informatics and evidence generation perspectives.

22 December 2021: RWD/RWE: A Year in Review (2021) – An open discussion attendee's top RWD/RWE stories or topics of 2021 and thoughts leading into a new year.